9. Does DONA™ have any effect on the progression of osteoarthritis?
These findings have been recently presented at the most important scientific congresses including the American College of Rheumatology meeting, where they attracted a huge attention and were welcome as the first evidence that a pharmacological intervention can prevent the progression of osteoarthritis. These data suggest therefore that DONA™ is the first disease-modifying agent in osteoarthritis.
These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.